Mohamed A. Soltan

Sinai University — Egypt

Medicine · Health Sciences

14h-index679citations56works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Urinary Bladder and Prostate Research(10), Urological Disorders and Treatments(10), vaccines and immunoinformatics approaches(8), Pediatric Urology and Nephrology Studies(6), Prostate Cancer Diagnosis and Treatment(5)

Publications56 total

Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential
Discover Oncology·2025Open Access
Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential
Discover Oncology·2025· 1 citedOpen Access
Application of Multi-Omics and Chemoinformatics to Analyze Oncogenic Roles and Assess Potential Inhibitors for NCAPG
Journal of Computational Biophysics and Chemistry·2025· 1 cited
Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy
International Immunology·2025· 5 citedOpen Access
MAD2L1 Induces Tumor Progression through Influencing Multiple Immune Components: A Multi-Omics Analysis with Potential Inhibitor Prediction
Journal of Computational Biophysics and Chemistry·2024Open Access
Exploring Ventilator-Associated Pneumonia: Microbial Clues and Biomarker Insights from a Retrospective Study
Medicina·2024· 3 citedOpen Access
Application of Reverse Vaccinology and Immunoinformatics to Design a Multitope Vaccine Against Gastrointestinal Cancer-Inducing <i>Cryptosporidium Parvum</i>
Journal of Computational Biophysics and Chemistry·2024· 1 cited
MP55-11 DO WE AGREE OR DISAGREE? EVALUATING CONCORDANCE OF UNDESCENDED TESTIS DIAGNOSIS BETWEEN REFERRING PROVIDERS AND UROLOGISTS
The Journal of Urology·2024
Deciphering Immune Complexity: Single-Cell Insights into Autoimmune Myocarditis Progression
2024Open Access
Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential Inhibitors
Pharmaceuticals·2024· 9 citedOpen Access
Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome
Biomedicines·2023· 9 citedOpen Access
Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy
Biology·2023· 10 citedOpen Access
A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
Frontiers in Molecular Biosciences·2023· 16 citedOpen Access
Genome-Based Analysis of the Potential Bioactivity of the Terrestrial Streptomyces vinaceusdrappus Strain AC-40
Biology·2023· 12 citedOpen Access
Integration of immunoinformatics and cheminformatics to design and evaluate a multitope vaccine against Klebsiella pneumoniae and Pseudomonas aeruginosa coinfection
Frontiers in Molecular Biosciences·2023· 21 citedOpen Access
Integration of Ultrastructural and Computational Approaches Reveals the Protective Effect of Astaxanthin against BPA-Induced Nephrotoxicity
Biomedicines·2023· 2 citedOpen Access
Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance
International Journal of Molecular Sciences·2023· 49 citedOpen Access
Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
Frontiers in Genetics·2023· 11 citedOpen Access
HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility
Frontiers in Immunology·2022· 8 citedOpen Access
Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis
International Journal of Molecular Sciences·2022· 27 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Muhammad Alaa Eldeen(20), Refaat A. Eid(18), Eman Fayad(17), Ahmed Abdelhalim(10), Tamer E. Helmy(9), Khaled M. Darwish(8), Mohamed Dawaba(8), Sarah Albogami(7), Ghadi Alsharif(7), Ashraf T. Hafez(7), Mohamed Samir Ahmed Zaki(6), Waleed K. Abdulsahib(6), Abdelwahab Hashem(6), Ahmed Atwa(6), Dalal Sulaiman Alshaya(6), Mahmoud Laymon(5), Ahmed M. Gouda(5), Sameh S. Elhady(5), Ayed A. Shati(5), Hesham M. Hassan(5)